Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach
Abstract The aim of our study was to investigate cerebrospinal fluid (CSF) tryptic peptide profiles as potential diagnostic biomarkers for the discrimination of parkinsonian disorders. CSF samples were collected from individuals with parkinsonism, who had an uncertain diagnosis at the time of inclus...
Guardado en:
Autores principales: | Tainá M. Marques, Anouke van Rumund, Iris Kersten, Ilona B. Bruinsma, Hans J.C.T. Wessels, Jolein Gloerich, Charlotte Kaffa, Rianne A. J. Esselink, Bastiaan R. Bloem, H. Bea Kuiperij, Marcel M. Verbeek |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/20d7ff2906c34b81b81ceb6c702ca96f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase
por: Anouke van Rumund, et al.
Publicado: (2021) -
Correction to: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy
por: Anna M. De Kort, et al.
Publicado: (2021) -
Quantitative Proteomics of Cerebrospinal Fluid in Paediatric Pneumococcal Meningitis
por: Guadalupe Gómez-Baena, et al.
Publicado: (2017) -
Cerebrospinal fluid glucose and lactate: age-specific reference values and implications for clinical practice.
por: Wilhelmina G Leen, et al.
Publicado: (2012) -
Cerebrospinal fluid proteome shows disrupted neuronal development in multiple sclerosis
por: Ellen F. Mosleth, et al.
Publicado: (2021)